# First Study in Humans With GSK424887

> **NCT01059591** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 26 (actual)

## Conditions studied

- Depressive Disorder and Anxiety Disorders

## Interventions

- **DRUG:** GSK424887
- **DRUG:** Placebo
- **RADIATION:** PET

## Key facts

- **NCT ID:** NCT01059591
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05-25
- **Primary completion:** 2007-01-25
- **Final completion:** 2007-01-25
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01059591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01059591, "First Study in Humans With GSK424887". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01059591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*